NU9056, a KAT 5 Inhibitor, Treatment Alleviates Brain Dysfunction by Inhibiting NLRP3 Inflammasome Activation, Affecting Gut Microbiota, and Derived Metabolites in LPS-Treated Mice

Lu Chen(XinHua Hospital), Fan Zhou(Central South University)

Frontiers in Nutrition

July 13, 2021

10.3389/fnut.2021.701760

Cited by 28

Related Papers

No related papers found

Powered by citation graph analysis